Milestone is developing and commercializing cardiovascular medicines using its lead product, CARDAMYST (etripamil) nasal spray.
1 report, 1 independent
Updated Aug 12
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Milestone is developing and commercializing cardiovascular medicines using its lead product, CARDAMYST (etripamil) nasal spray.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Milestone
American record label